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Exploring the potential effect and mechanisms of protocatechuic 
acid on human hair follicle melanocytes
This study aims to evaluate the effect of protocatechuic acid 
(PCA) on human hair follicle melanocytes (HFM). Normal pri-
mary HFM were isolated and cultured till logarithmic period 
of second passage, then treated with different concentrations 
of PCA (0.1–200 μmol L–1) to study the cell proliferation, mela-
nin contents, tyrosinase activity and protein and mRNA ex-
pression of melanogenic genes (tyrosinase-related protein 1 
(TRP-1), tyrosinase-related protein 2 (TRP-2), and microph-
thalmia-associated transcription factor (MITF)) in the cul-
tured HFM. In addition, we have also measured the contents 
of superoxide dismutase (SOD) and glutathione (GSH) in PCA 
treated HFM. Vitamin C was used as a positive control. The 
result showed that PCA can decrease the synthesis of melanin 
and the tyrosinase activity with IC50 = 8.9 μmol L–1 and IC50 = 
6.4 μmol L–1, respectively, at the treatment time of 24 hours, 
without inducing any cytotoxicity in HFM cells. In addition, 
the mRNA transcription and protein expression levels of TRP-1, 
TRP-2 and MITF significantly decreased with a dose-depen-
dent manner after 24-hour PCA treated in HFM cells. Further-
more, PCA has significantly increased the SOD and GSH 
activity in a dose-dependent manner for 24-hour PCA treat-
ment. This study suggested that PCA has an inhibitory effect 
on the production of melanin through down-regulation of the 
expression of melanogenesis-related protein and the effect of 
anti-oxidation, which could be useful for the therapy of mela-
nin overproduction or skin whitening.
Keywords: protocatechuic acid, human hair follicle melano-
cytes, melanin synthesis, tyrosinase activity, anti-oxidation
Protocatechuic acid (3,4-dihydroxybenzoic acid, PCA, Fig. 1), the main metabolite of 
anthocyanins, is one of the effective components of many Chinese traditional medicines, 
widely distributed in fruits and vegetables such as tea, grape, raspberry, chicory, cauli-
flower, and buckwheat, but in low concentrations (1). Recent studies have reported that 
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diabetes, anti-infection, anti-aging, neuro-protection, anti-virus, promoting stem cell pro-
liferation and differentiation (2, 3). In addition, PCA can scavenge 1,1-diphenyl-2-trinitro-
phenyl hydrazine (DPPH), nitric oxide (NO), hydrogen peroxide free radicals (4). So far, 
PCA is considered to be nontoxic and a relatively safe compound for oral administration. 
Melanin, a pigment, is synthesized by melanocytes in the epidermis basal layer. After 
being synthesized, melanin is transferred to epidermal keratinocytes via dendritic pro-
cesses (5). Melanin overexpression leads to hyperpigmentation, which will further cause 
pigmentary disorders such as melasma, freckles, and age spots (6). To address these issues, 
researchers have developed anti-melanogenic agents such as arbutin, kojic acid, and hy-
droquinone; however, many anti-melanogenic agents usually exert slight whitening ef-
fects or more severe side effects.
Anti-melanogenic agents are usually reported to target the activation or expression of 
tyrosinase. Tyrosinase is a complex multi-subunit copper-containing oxidoreductase, 
which is the key enzyme and rate-limiting enzyme for melanin synthesis in organisms. 
Tyrosinase inhibitors have great potential in the treatment of melanin metabolic diseases 
and cosmetics (7). Currently, tyrosinase inhibitors are mainly obtained from chemical syn-
thesis or extraction of natural products. It is of great significance in practical application to 
find the high-efficiency and safe tyrosinase inhibitors.
As a phenolic acid, PCA has a similar parent nucleus structure to many hydroxyben-
zoate tyrosinase inhibitors, which suggests that PCA may be a potential tyrosinase in-
hibitor. Thus, in this study, we aimed to evaluate the effect of PCA on human hair follicle 
melanocytes (HFM) including cell proliferation, melanin synthesis, tyrosinase activity 
and the expression of melanogenesis-related genes, in order to find a potential therapy for 
melanin overexpression disease or skin whitening keeping reagent.
EXPERIMENTAL
Chemicals
EMEM culture medium (Gibco), Keratinocyte serum-free medium (KSFM, Gibco), Fetal 
bovine serum (FBS, Hyclone), 0.25–0.50 % separation enzyme (Sigma), cholera toxin (CT, 
Sigma), 12-o-tetradecanoylphobol-13-acetate (TPA, Sigma), geneticin (G418, Sigma), 3-isobu-
tyl-1-methylxanthine (IBMX, Sigma), bFGF (Sigma), methylthiazolyldiphenyl tetrazolium 
bromide (MTT, Shanghai Huamei Bioengineering Company), MGM (EMEM medium, 10 % 
FBS, 0.2 μg mL–1 CT, 50 nmol L–1 TPA and 50 % KSFM), 0.1 % L-dopa (Sigma). Superoxide 
Fig. 1. The chemical structure and HPLC analysis of PCA.
541
B. Li et al.: Exploring the potential effect and mechanisms of protocatechuic acid on human hair follicle melanocytes, Acta Pharm. 70 
(2020) 539–549.
 
dismutase (SOD) and glutathione (GSH) kits were obtained from Nanjing Jiancheng Bioen-
gineering Institute (Nanjing, China). Anti-MITF antibody (ab20663) and anti-TRP1 antibody 
(ab3312) were purchased from Abcam. Anti-TRP2 antibody (sc-74439) and anti-b-actin anti-
body (sc-47778) were purchased from Santa Cruz Biotechnology. Protocatechuic acid was 
purchased from MedChemExpress LLC, USA (HY-N0294, purity 99.95 %).
HPLC analysis for the purity of PCA
The chemical structure of PCA was identified by 1H and 13C NMR spectral data. The 
purity of PCA was analyzed by HPLC-PDA method. In short, a Waters 2695 Alliance HPLC 
system combined with Waters 2998 PDA detector and the Scienhome Kromasil C18 column 
(4.6 mm × 250 mm, 5 μm) at a column temperature of 30 °C were used. The mobile phase 
used was (A) 0.1 % formic acid in water and (B) acetonitrile, which started with 10 to 45 % B 
in 0–10 min; 45 to 95 % B in 10–30 min; 95 to 95 % B in 30–35 min; 95 to 10 % B in 35–40 min.
Cell isolation and cell culture
Normal human scalp (about 10–15 cm2) was obtained from six women (mean age 40 
years) in routine plastic surgery at the people’s Hospital of Hunan province (Changsha, 
China). The HFM isolation was done according to the method Tobin et al. had reported (8). 
Removal of the epidermis and upper part of dermis 1 mm, cut into strips about 0.5 cm wide 
and 3–4 cm long; immersed in 0.25–0.50 % separation enzyme solution, and stored at 4 °C 
for 12–16 h. Free hair follicles were digested at 37 °C with 0.25 % trypsin for 10–15 minutes 
to form a single cell suspension. Melanocyte growth medium (MGM) was added to the 
cells and then dripped into a 35 mm plastic culture dish or flask. The inoculation density 
was 3–5 × 104 cm–2. Then cultured for 4–5 weeks at 37 °C, 5 % CO2 incubator, and the pure 
HFM (about 5–10 × 106) was obtained after 1–2 times passages. Use the differential pancre-
atin to remove the contaminated keratinocytes, and use G418 to remove the contaminated 
fibroblasts. After 1 week of culture, the morphology of HFM was observed at a high magni-
fication microscope, and dopamine staining was performed. The study was approved by 
the medical ethics committee of the people’s Hospital of Hunan province/1st Affiliated 
Hospital of Hunan Normal University, Changsha, Hunan, China. The approval form number 
is 15 of the 2017 scientific research ethics review.
Dopamine staining
The cells were cultured and seeded on the cover slide. Phosphate buffer saline (PBS) 
was used to wash the cells, followed by fixing the cells in 2 % polyformaldehyde (PFA) 
solution for 10 min, and then wash with PBS 3 times. 0.1 % dopamine (in 0.1 mol L–1 PBS 
solution) was used for staining at 37 °C for 5 h. The cell nuclei were dyed with eosin, then 
imaged under the bright field microscope.
Effects of PCA on HFM cell proliferation
The effect of PCA on HFM cell proliferation was measured by the methylthiazolyl-
diphenyl-tetrazolium bromide (MTT) assay. HFM cells were seeded at a concentration of 
5000 cells per well, 200 μL medium per well for 96-well plates. Then the cells were cultured 
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at 37 °C, 5 % CO2 incubator for 12 h before drug treatment. The cell proliferation activity was 
detected at the gradient dilution concentrations of PCA (0.1, 0.3, 1, 3, 10, 30, 100, 200 μmol L–1) 
in the time course of 24, 48, and 72 h, respectively. After the drug incubation, the cell medium 
was removed and washed twice with PBS solution, after which 100 μL of fresh cell medium 
containing 20 μL MTT solution was added to each well and incubated at 37 °C, 5 % CO2 
 incubator for 4 h. Cell plates were centrifuged at 1000 rpm, 10 min, in order to make the 
formazan crystals adhere to the flat plate bottom, then the supernatants were discarded 
carefully, and 100 μL of DMSO was added to each well. Plates were shaken on a plate shaker 
with the shaking speed of 900 shakes min–1, for 10 min to make sure that the formazan 
 crystals were thoroughly dissolved. The plate absorbance (A) was measured at a wavelength 
of 570 nm by a microplate reader. The cell viability was calculated using Equation 1.
 Cell viability % = 100 – (Avehicle – Adrug)/Avehicle × 100 (1)
where A is the absorbance value detected at the wavelength of 570 nm. The experiments 
were performed in triplicates and repeated three times.
Melanin content determination
HFM cells were pre-treatment with the indicated dosage of PCA (1, 3, 10, 30 and 100 
μmol L–1) and vitamin C (100 μmol L–1) respectively for 2 hours, and then 0.15 μmol L–1 of 
alpha-melanocyte-stimulating hormone (a-MSH) was added and the cells were incubated 
for 24 and 48 h, respectively. Melanin content was determined according to the method of 
Wojcik et al. (9). HFM cells were counted by the blood cell counter (repeated four times to 
get the mean value). The cells were washed twice with PBS solution, then 200 μL of double 
steaming water was added to suspend the cells. 1 mL of the mixed solution of ethanol and 
ether (1:1) was added, left at room temperature for 15 min, and centrifuged for 5 min (3000 
rpm min–1). The supernatant was discarded and 1 mL of 1 mol L–1 NaOH (containing 10 % 
DMSO) was added to the tube to dissolve the melanin at 80 °C for 30 min. Finally, 4 mL of 
double steaming water was added to dilute NaOH to 0.2 mol L–1. The absorbance of mela-
nin was determined by spectrophotometer at 475 nm using Equation 2. Each experiment 
was repeated four times.
Relative melanin content % =  (A475/cell numbers in the related group)/ 
 (A475/cell numbers in alone a-MSH induced group) × 100 (2)
Tyrosinase activity determination
HFM cells were pre-treated with the indicated dosage of PCA (1, 3, 10, 30 and 100 μmol 
L–1) and vitamin C (100 μmol L–1) respectively for 2 hours, and then 0.15 μM of a-MSH was 
after which the cells were incubated for 24 h. The determination of tyrosinase activity was 
done according to Kim et al. (10) and with a little improvement of the method. Cells were har-
vested and counted, washed with PBS twice, after which 1 mL of 0.5 % sodium deoxycholate 
lysate was added and the cells suspended and placed at 4 °C for l h, followed by centrifuge at 
4 °C (10 000 rpm min–1) for 20 min to obtain the supernatant containing tyrosinase. l mL of 
supernatant was added to 3.0 mL (2.5 mol L–1 L-dopa, 0.1 mol L–1 PBS, pH 6.8) of L-dopamine 
reaction solution and incubated at 37 °C for 20 minutes. The absorbance of dopa pigments was 
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determined by spectrophotometer at 475 nm using Equation 3. At the same time, the auto-
matic oxidation of L-dopa was used for correction. Each experiment was repeated 4 times.
Tyrosinase activity % = (A475/cell numbers in the related group) / 
 (A475/cell numbers in alone a-MSH induced group) × 100 (3)
Western blot analysis
HFM cells were seeded in 48-well plates at a density of 1 × 105 cells per well, cultured 
at 37 °C, 5 % CO2 for 24 h. Following day, the cells were pre-treated with the indicated dos-
age of PCA (1, 10 and 100 μmol L–1) and vitamin C (100 μmol L–1) respectively for 2 hours, 
after which 0.15 μM a-MSH was added to each well and incubated for 72 h. The total pro-
teins were extracted from the cells using Radio Immunoprecipitation Assay buffer (Sigma 
Aldrich, USA) and quantified using the BCA kit (Thermo Fisher Scientific, USA). The pro-
teins were separated by 10 % SDS-PAGE gel and transferred to PVDF membrane (Milli-
pore, USA). The membrane was blocked with 5 % non-fat milk for 1 h at room temperature 
(r.t.) and incubated overnight with primary antibody (dilution ratio, 1:1000 for MITF and 
TRP-1; 1:500 for TRP-2; 1:5000 for b-actin) at 4 °C. The membrane was washed three times 
with 1 × TBST and incubated with the related secondary antibodies for 1 h at r.t. The mem-
brane was washed three times with 1 × TBST, then exposed with the Chemiluminescent 
Substrate (Thermo Fisher Scientific, USA) and imaged on the instrument of BioRad Chemi-
Doc XRS+ (BioRad, USA).
Quantitative reverse transcription-polymerase chain reaction (RT PCR) analysis
HFM cells were seeded into 48-well plates at a density of 1 × 105 cells per well, then 
treated with PCA (1, 10 and 100 μmol L–1) and vitamin C (100 μmol L–1) respectively for 2 
hours, after which 0.15 μM a-MSH was added to each well and incubated for 72 h. Total RNA 
samples were extracted with Trizol reagent (Invitrogen, Thermo Fisher Scientific, USA) fol-
lowing the manufacturer’s protocols. Single-stranded cDNA was obtained via reverse tran-
scribe of the total RNA (1 μg) with the SuperScript®III First-Strand Synthesis System 
(18080051, Thermo Fisher Scientific, USA). The cDNA was amplified in an automated ther-
mal cycler (MyGene Series Thermal Cycler MG96G, China). The primer sequences were as 
follows: MITF (438 bp): forward 5’-CAAATGGCAAATACGTTACCCG-3’, reverse 
5’-CTCCCTTTTTATGTTGGGAAGGT-3’; TRP1 (499 bp): forward 5’-TACAGTGGAAGGTTA-
CAGTG-3’, reverse 5’-AGCATAGCGTTGATAGTGAT-3’; TRP2 (444 bp): forward 5’-ATA-
ACTTGGCTCACTCCTTC-3’, reverse 5’-CTTCCTCCGTGTATCTCTTG-3’; b-actin (446 bp): 
forward 5’-GAGACCTTCAACACCCCGC-3’, reverse 5’-CCACAGGATTCCATACCCAA-3’. 
The b-actin gene was amplified separately as an internal control to normalize the gene ex-
pression in the samples. The PCR conditions were 5 min at 94 °C followed by 32 cycles of 20 
s at 94 °C, 20 s at 60 °C, 1 min at 72 °C, and 10 min at 72 °C. Then PCR products were electro-
phoresed at 1.5 % agarose gel and analysed with a UV trans-illuminator.
Anti-oxidative marker detection
SOD and GSH activities were determined by a commercially available kit according 
to the manufacturer’s protocol. SOD reaction was detected at 550 nm (Thermo Scientific 
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Multiskan GO microplate reader, USA) and the values were expressed as U mg–1 protein, 
GSH reaction was measured at 420 nm and the values were expressed as mg g–1 protein.
Statistical analysis
The biological values in the study were displayed as means ± SD. All the statistical 
comparisons between the groups were performed by one-way ANOVA with Dunnett’s 
t-test in the GraphPad Prism 6.0 software.
RESULTS AND DISCUSSION
The chemical structure identification by NMR was 1H NMR (CD3OD, 400 MHz) δ (H) 
(J in Hz): 7.41 (1H, d, J = 2.4 Hz), 6.80 (1H, d, J = 8.0 Hz), 7.44 (1H, dd, J = 8.0, 2.4 Hz). 13C NMR 
Fig. 2. The effect of PCA on the cell proliferation of HFM: a) the cell morphology of HFM was ob-
served under a photomicroscope (original magnification × 200, scale bar: 100 μm); b) HFM showed a 
positive signal by dopamine staining (original magnification × 200, scale bar: 100 μm); c) effects of 
PCA on HFM cell proliferation in the indicated times (24, 48 and 72 h). Data are presented using three 
independent experiments. PCA, protocatechuic acid; HFM, human hair follicle melanocytes.
a)                                                                             b)
c)
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(CD3OD, 100 MHz) δ(C): 123.2, 117.8, 146.2, 151.6, 115.9, 124.0, 170.4. The purity of PCA ana-
lyzed by HPLC showed in Fig. 1. The above data showed that the purchased PCA is correct 
and has a high purity, which is suitable for its cell biology detection.
To evaluate the effect of PCA on HFM, we have isolated the HFM from normal human 
head skin, according to the isolation method of Tobin et al. (8). After 1 week, we have  imaged 
the cell morphology and stained the cells with dopamine (Fig. 2). The HFM morphology 
showed that there are 3 to 5 dendrites in epidermal melanocytes, with smaller cell bodies 
and stronger refractive index (Fig. 2a), while the dopamine staining showed a positive 
signal (Fig. 2b).
To examine the effect of PCA on the cell proliferation of HFM, we used 8 gradient 
dilution concentrations of PCA (0.1, 0.3, 1, 3, 10, 30, 100, 200 μmol L–1) to detect the cell 
proliferation changes at the time course of 24, 48, and 72 h, respectively. The cells were 
seeded to 96-well plate at a density of 5000 cells per well, and the cell viability was mea-
sured by MTT assay. From Fig. 2, we can see that PCA treatment did not significantly in-
hibit the cell proliferation of HFM in a concentration- or time-dependent manner (Fig. 2c), 
which was similar to the activity of vitamin C. This result suggested that PCA could not 
induce the cytotoxicity of HFM in vitro culturing at the treatment time of 72 h (Fig. 2c).
Next, we have detected the effect of PCA on the synthesis of melanin in HFM cels, 
according to the detection method of Wojcik et al. (9). In the experiment, we have detected 
the effect of PCA on the synthesis of melanin in five different concentrations (1, 3, 10, 30, 
100 μmol L–1) at 24 and 48 h respectively. As shown in Fig. 3, PCA has significantly reduced 
the a-MSH-induced melanin content in a dose-depended manner compared to the a-
MSH-induced melanin synthesis group with the IC50 of 8.9 and 2.6 μmol L–1 at the treat-
ment time of 24 and 48 h respectively (p < 0.05, p < 0.01, p < 0.001, Fig. 3). Vitamin C had also 
significantly decreased the synthesis melanin at 24 and 48 h treatment at the concentration 
of 100 μmol L–1 (Fig. 3).
Since PCA has a similar parent nucleus structure to many hydroxybenzoate tyrosi-
nase inhibitors, we decided to measure the effect of PCA for the tyrosinase activity on 
Fig. 3. The effect of PCA on melanin contents: a) relative melanin content after 24 h treatment of PCA; 
b) relative melanin content after 48 h treatment of PCA. Values were calculated relative to alone 
a-MSH induced group and represented the mean ± SD of three independent replicates. *p < 0.05, 
**p < 0.01, ***p < 0.001 vs. alone a-MSH induced group. PCA, protocatechuic acid.
a)                                                                             b)
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Fig. 4. The effect of PCA on tyrosinase activity. Values were calculated relative to alone a-MSH 
 induced group and represented the mean ± SD of three independent replicates. *p < 0.05, **p < 0.01, 
***p < 0.001 vs. alone a-MSH induced group. PCA, protocatechuic acid.
Fig. 5. Effects of PCA on the protein expression of TRP1, TRP2 and MITF: a) the protein expression of 
TRP1, TRP2 and MITF at the treatment of different PCA concentrations were determined by Western 
blotting; b) quantification of the protein levels of TRP1, TRP2 and MITF by image J software. b-actin 
used as the internal control. Values were calculated relative to alone a-MSH induced group and 
represented the mean ± SD of three independent replicates. Statistical significance is indicated as 
*p < 0.05, **p < 0.01, ***p < 0.001 vs. alone a-MSH induced group. PCA, protocatechuic acid.
a)           
b)
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Fig. 6. Effects of PCA on mRNA expression of TRP1, TRP2 and MITF: a) mRNA expression of TRP1, 
TRP2 and MITF at the treatment of different PCA concentrations were determined by RT-PCR; b) 
quantification of the mRNA levels of TRP1, TRP2 and MITF by image J software. b-actin used as the 
internal control. Values were calculated relative to alone a-MSH induced group and represented the 
mean ± SD of three independent replicates. Statistical significance is indicated as *p < 0.05, **p < 0.01, 
***p < 0.001 vs. alone a-MSH induced group. PCA, protocatechuic acid.
HFM (Fig. 4) (10). Compared with a-MSH-induced melanin synthesis group, PCA had 
significantly decreased the activity of tyrosinase in all concentrations of PCA (1, 3, 10, 30, 
100 μmol L–1) in a dose-depended manner (p < 0.05, p < 0.01, p < 0.001, Fig. 4), with the IC50 
of 6.4 μmol L–1 for PCA inhibition of tyrosinase activity. While the vitamin C treated group 
has also shown a reduced activity of tyrosinase at the concentration of 100 μmol L–1, com-
parable to the a-MSH-induced melanin synthesis group (p < 0.01, Fig. 4).
To further investigate the molecular mechanisms of PCA on melanogenesis regula-
tion, the levels of melanogenic genes and proteins were examined (11–15). As shown in Fig. 
5, the effect of PCA on the expression of TRP-1, TRP-2 and MITF proteins was assessed 
with the Western blot method. The result showed that PCA had significantly inhibited a-
MSH-induced expression of TRP-1, TRP-2 and MITF in HFM cells (p < 0.01, p < 0.001, Fig. 
5). In addition, we have also detected the mRNA expression of TRP-1, TRP-2 and MITF 
under the conditions of a-MSH triggered by RT-PCR (Fig. 6). From Fig. 6, we can see that 
PCA treatment had significantly decreased TRP-1, TRP-2 and MITF mRNA expression in 
dose-depended manners (p < 0.05, p < 0.01, p < 0.001, Fig. 6). Taken above, the result shows 
a)           
b)
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that the inhibitory effects of PCA on melanogenesis may be related to the down-regulation 
of melanogenic genes and proteins (e.g. TRP-1, TRP-2 and MITF).
The two important antioxidant enzyme SOD and GSH are often used to evaluate the 
ability of anti-oxidative (7). In Table I, the result shows a significant difference in antioxi-
dant levels after PCA treatment for 24 h in HFM cells. From Table I, we can see that, PCA 
significantly increased the activity of SOD and GSH in a dose-dependent manner (1–100 
μmol L–1, p < 0.05, p < 0.01), which implies that the action mechanism of PCA may be re-
lated to its anti-oxidative effects.
CONCLUSIONS
PCA could reduce a-MSH-induced melanin synthesis, inhibit the tyrosinase activity, 
down-regulate of the expression of TRP-1, TRP-2 and MITF, and increase the levels of SOD 
and GSH in HFM cells, with almost no cytotoxicity to HFM. Thus, the findings implied 
that PCA can be used as a potential depigmenting agent for the therapy of melanin over-
expressed disease or skin whitening.
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